• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HERO HEALTH INC HERO 100; PILL DISPENSER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HERO HEALTH INC HERO 100; PILL DISPENSER Back to Search Results
Model Number H100
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Cardiovascular Insufficiency (4445)
Date of Event 01/05/2023
Type of Reportable Event Serious Injury
Event or Problem Description
On 1/5 the user requested a replacement device due to automatic dispense failure and pill count issues.On 1/6 the user additionally reported that the device was notifying them that all the pills were dispensed, when they were not.Moreover, some of the medications were empty in the past due to the user not refilling the medications through the pharmacy, and after nearly two months not being able to get the medications they were hospitalized.The user also reported being taken to the emergency room with a heart failure, due to some of the medications being inside the device however out of the hero smart system schedule.They were unaware that these medications were not dispensed.
 
Additional Manufacturer Narrative
The hero device should not be used by a recipient of medication who is incapable of verifying the accuracy of each dispensed dose (such as those suffering from dementia or other cognitive or physical impairments) unless pill dispense accuracy is being verified, in each instance, by qualified person(s) trusted by the medication recipient, i.E.A caregiver, a healthcare aide, and/or a healthcare professional.The medication recipient (or a trusted qualified person) must always verify that the types of pills and number of pills dispensed by the hero device match the prescribed or desired dosage before ingesting the contents of the pill cup.The hero device should not be used to dispense medicines that have high dosage sensitivity, that have a narrow therapeutic window, that are used to treat acute conditions or that are used to treat life-threatening events.Even though the hero device is capable of successfully and accurately dispensing most whole pills loaded into the device on most occasions, hero cannot guarantee the accuracy of medication dispensed during every dispense cycle due to the potential for human error and/or mechanical and software limitations or failures.
 
Event or Problem Description
On 1/5 the user requested a replacement device due to automatic dispense failure and pill count issues.On 1/6 the user additionally reported that the device was notifying them that all the pills were dispensed, when they were not.Moreover, some of the medications were empty in the past due to the user not refilling the medications through the pharmacy, and after nearly two months not being able to get the medications they were hospitalized.The user also reported being taken to the emergency room with a heart failure, due to some of the medications being inside the device however out of the hero smart system schedule.They were unaware that these medications were not dispensed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HERO 100
Common Device Name
PILL DISPENSER
Manufacturer (Section D)
HERO HEALTH INC
85 broad street
new york NY 10004
Manufacturer (Section G)
HERO HEALTH INC
85 broad street
new york NY 10004
Manufacturer Contact
fred tobia
85 broad street
new york, NY 10004
8558559962
MDR Report Key16276816
Report Number3014660737-2023-45868
Device Sequence Number18508556
Product Code NXB
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)Y
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Remedial Action Replace
Type of Report Initial,Followup
Report Date (Section B) 04/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model NumberH100
Was Device Available for Evaluation? Device Returned to Manufacturer
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/05/2023
Supplement Date Received by Manufacturer01/05/2023
Initial Report FDA Received Date02/01/2023
Supplement Report FDA Received Date04/06/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/09/2020
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
LISINOPRIL 2.5 MG-UNABLE TO CONFIRM; LISINOPRIL 2.5 MG-UNABLE TO CONFIRM; SPIRONOLACTONE 25 MG-UNABLE TO CONFIRM; SPIRONOLACTONE 25 MG-UNABLE TO CONFIRM
Outcome Attributed to Adverse Event Hospitalization;
Patient SexUnknown
-
-